Filing Details

Accession Number:
0000899243-19-019449
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-10 18:03:07
Reporting Period:
2019-07-10
Accepted Time:
2019-07-10 18:03:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1422142 Aerpio Pharmaceuticals Inc. ARPO Pharmaceutical Preparations (2834) 611547850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1700816 H. Joseph Gardner C/O Aerpio Pharmaceuticals, Inc.
9987 Carver Road, Suite 420
Cincinnati OH 45242
President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-07-10 5,000 $0.81 453,019 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 150,000 Indirect See Footnote
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.80 to $0.8217, inclusive. The reporting person undertakes to provide to Aerpio Pharmaceuticals, Inc., any security holder of Aerpio Pharmaceuticals, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
  2. These shares are owned by a Family Trust for the benefit of the reporting person's children. The reporting person's sibling is the trustee of the trust. The reporting person disclaims beneficial ownership of these shares.